Terms: = Lung cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
7119 results:
1. [A Growth Prediction Model of Pulmonary Ground-Glass Nodules Based on Clinical Visualization Parameters].
Zhou YY; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):169-175. PubMed ID: 38686712
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells.
Ascenzi F; Esposito A; Bruschini S; Salvati V; De Vitis C; De Arcangelis V; Ricci G; Catizione A; di Martino S; Buglioni S; Bassi M; Venuta F; De Nicola F; Massacci A; Grassucci I; Pallocca M; Ricci A; Fanciulli M; Ciliberto G; Mancini R
Cell Death Dis; 2024 Apr; 15(4):303. PubMed ID: 38684666
[TBL] [Abstract] [Full Text] [Related]
3. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract] [Full Text] [Related]
4. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
[No Abstract] [Full Text] [Related]
5. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in lung Adenocarcinoma and Squamous Cell Carcinoma.
Koh YW; Han JH; Haam S; Lee HW
Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
[TBL] [Abstract] [Full Text] [Related]
6. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in lung cancer.
Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs.
Martin T; Rioufol C; Favier B; Martelli N; Madelaine I; Chouaid C; Borget I
BioDrugs; 2024 May; 38(3):465-475. PubMed ID: 38643301
[TBL] [Abstract] [Full Text] [Related]
8. Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.
Zheng L; Hu F; Huang L; Lu J; Yang X; Xu J; Wang S; Shen Y; Zhong R; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38641349
[TBL] [Abstract] [Full Text] [Related]
9. Utilizing Deep Learning and Computed Tomography to Determine Pulmonary Nodule Activity in Patients With Nontuberculous Mycobacterial-lung Disease.
Lancaster AC; Cardin ME; Nguyen JA; Mehta TI; Oncel D; Bai HX; Cohen KA; Lin CT
J Thorac Imaging; 2024 May; 39(3):194-199. PubMed ID: 38640144
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
[TBL] [Abstract] [Full Text] [Related]
11. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
12. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
Wang B; Hou C; Yu X; Liu J; Wang J
Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
[TBL] [Abstract] [Full Text] [Related]
14. Enhancing diagnosis of benign lesions and lung cancer through ensemble text and breath analysis: a retrospective cohort study.
Wang H; Wu Y; Sun M; Cui X
Sci Rep; 2024 Apr; 14(1):8731. PubMed ID: 38627587
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Utility of a CT-based AI Prognostic Model for Segmentectomy in Non-Small Cell lung cancer.
Na KJ; Kim YT; Goo JM; Kim H
Radiology; 2024 Apr; 311(1):e231793. PubMed ID: 38625008
[TBL] [Abstract] [Full Text] [Related]
16. Architecting the metabolic reprogramming survival risk framework in LUAD through single-cell landscape analysis: three-stage ensemble learning with genetic algorithm optimization.
Sun X; Nong M; Meng F; Sun X; Jiang L; Li Z; Zhang P
J Transl Med; 2024 Apr; 22(1):353. PubMed ID: 38622716
[TBL] [Abstract] [Full Text] [Related]
17. Multiomics-Based Feature Extraction and Selection for the Prediction of lung cancer Survival.
Jaksik R; Szumała K; Dinh KN; Śmieja J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612473
[TBL] [Abstract] [Full Text] [Related]
18. Boosting predictive models and augmenting patient data with relevant genomic and pathway information.
Buosi S; Timilsina M; Torrente M; Provencio M; Fey D; Nováček V
Comput Biol Med; 2024 May; 174():108398. PubMed ID: 38608322
[TBL] [Abstract] [Full Text] [Related]
19. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
20. Predictors of cancer-specific survival and overall survival among patients aged ≥60 years with lung adenocarcinoma using the SEER database.
Li F; Li F; Zhao D; Lu H
J Int Med Res; 2024 Apr; 52(4):3000605241240993. PubMed ID: 38606733
[TBL] [Abstract] [Full Text] [Related]
[Next]
